James Farrell, MBChB, is an internationally recognized expert in gastrointestinal endoscopy and pancreatic diseases. He maintains a busy clinical practice focused on all aspects of interventional endoscopy, gastrointestinal cancer, and pancreatic diseases including endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) evaluation of pancreatic cancer, pancreatic cysts, pancreatitis, and individuals at risk for pancreatic malignancy.
“My main clinical commitment is to take care of the patient, and specifically improve outcomes for patients with pancreatic disease, either by early diagnosis or by optimizing treatment,” he says. “I tell patients and their families that there are many diagnostic and treatment options available, and my goal is to guide them in choosing the appropriate options using evidence-based medicine.”
In addition to his clinical work and research, Dr. Farrell is director of the Yale Medicine Pancreatic Diseases Program, which brings together a variety of pancreatic specialists including gastroenterologists, surgeons, oncologists, and nurses who focus on pancreatic disease. “The multidisciplinary approach to the diagnosis and management of pancreatic disease ensures patient access to the "state-of-the-art" advances in this field, and ensures best patient outcomes," Dr. Farrell says.
Dr. Farrell has addressed pancreatic disease on a national and international level as a member of such organizations as the NIH/NCI Pancreas Cancer Task Force. As a researcher, he is known for his development of personalized therapy approaches and early detection biomarkers for pancreatic cancer.
He is professor of medicine (digestive diseases) at Yale School of Medicine.
